TrialsAlert vs ClinicalTrials.gov: The Best ClinicalTrials.gov Alternative for Patients (2026)
Automated monitoring vs manual search
By Victor Lafforgue, Founder of TrialsAlert. Last updated April 2026. TrialsAlert is our product. See our editorial policy.
ClinicalTrials.gov is the essential source of clinical trial data. It is free, comprehensive, and maintained by the U.S. National Library of Medicine. But as a monitoring tool, most patients and caregivers find it overwhelming. Searching through 400,000 trials every week to find what is relevant to a single condition takes 5 or more hours and requires reading clinical protocol language. If you are looking for a ClinicalTrials.gov alternative that watches the database for you and explains new trials in plain English, TrialsAlert is purpose-built for that use case. This page is an honest, side-by-side comparison, including pricing, features, and who should pick which.
Feature comparison
| Feature | TrialsAlert | ClinicalTrials.gov |
|---|---|---|
| Data source | ClinicalTrials.gov API v2 (synced daily) | Primary registry |
| Update frequency | Scans daily; weekly briefing delivered every Friday | Continuous registry updates |
| AI scoring | Six dimensions: phase importance, breakthrough potential, patient accessibility, condition prevalence, sponsor credibility, relevance | None |
| Alert delivery | Weekly email briefing per tracked condition | None (manual search required) |
| Pricing | From EUR 11/month (Single). EUR 19/month (Universal, 3 conditions). 27% off quarterly. | Free |
| Patient vs researcher focus | Built exclusively for patients and caregivers | Neutral registry; serves patients, researchers, sponsors |
| Number of conditions | 400,000+ trials tracked; 1 or 3 conditions per subscription | 400,000+ trials, unlimited |
| Language support | English and French UI; briefings in plain English | English primarily |
What is ClinicalTrials.gov?
ClinicalTrials.gov is a free, publicly accessible database maintained by the U.S. National Library of Medicine at the National Institutes of Health. It contains over 400,000 clinical trials across every medical condition and is the most comprehensive source of clinical trial data available. Researchers and sponsors are required by law to register their trials on ClinicalTrials.gov, which is why it is considered the authoritative source of record. Anyone can search by condition, treatment, location, phase, or sponsor. ClinicalTrials.gov is indispensable for the clinical research ecosystem, but it was designed as a registry, not as a patient monitoring tool.
How is TrialsAlert different from ClinicalTrials.gov?
ClinicalTrials.gov is a search engine. You go to it, enter a query, and browse results. TrialsAlert is a monitoring service. You tell it your condition once, and it watches ClinicalTrials.gov for you every day. When new trials appear or existing trials are updated, TrialsAlert's AI scores them across six dimensions then classifies them as breakthrough, notable, or routine. Every Friday, you receive a plain-language briefing explaining what changed and why it matters. No medical jargon, no manual searching, no missed trials. TrialsAlert also generates doctor-ready reports that patients can email to their physician or bring to appointments, something ClinicalTrials.gov does not provide.
Can you use both together?
Yes, and many patients do. TrialsAlert monitors ClinicalTrials.gov on your behalf and surfaces what matters in a weekly briefing. When a trial catches your attention, you can open its ClinicalTrials.gov record directly from the briefing for the full details: eligibility criteria, locations, contact information, and study design. TrialsAlert-generated doctor reports include direct ClinicalTrials.gov links so your physician can go deeper when needed.
Who should choose ClinicalTrials.gov
Choose ClinicalTrials.gov directly when you want to look up a specific trial by its NCT identifier, read the raw eligibility criteria for a study, contact a study team directly, or do your own research without an intermediary. It is the authoritative source, it is free, and nothing else on the market replaces it. Researchers, sponsors, site coordinators, and academic investigators should work from ClinicalTrials.gov as their primary source of truth. Journalists and patient advocacy organizations reporting on trial activity should cite ClinicalTrials.gov as the primary reference. TrialsAlert is not a replacement for ClinicalTrials.gov. It is a monitoring and translation layer on top of it.
Who should choose TrialsAlert
Choose TrialsAlert if you are a patient or caregiver tracking a specific medical condition and you want new and updated trials surfaced to you without manually searching. TrialsAlert is built for the user who says: "I don't have 5 hours a week to wade through clinical protocol language. I want the research that matters to me, explained in plain English, delivered every Friday." The doctor-ready report feature is particularly useful for patients who want to discuss specific trials with their oncologist, neurologist, or specialist at their next appointment. A weekly briefing is also the right fit for adult children or siblings who are tracking a parent's diagnosis and want to arrive at appointments better informed.
Frequently asked questions
Is TrialsAlert a replacement for ClinicalTrials.gov?
No. TrialsAlert is a monitoring service that uses ClinicalTrials.gov as its data source. Every trial surfaced in a TrialsAlert briefing links back to the original ClinicalTrials.gov record for full details. Think of TrialsAlert as a curation and translation layer on top of the authoritative registry.
Is the clinical trial data the same on both services?
Yes. TrialsAlert fetches trials daily via the ClinicalTrials.gov API v2, so the underlying trial records are identical. The difference is how the information is presented. ClinicalTrials.gov shows the raw protocol data. TrialsAlert scores, classifies, and explains each trial in plain language.
Why would I pay for TrialsAlert when ClinicalTrials.gov is free?
You pay for time, not data. Patients tracking a condition on ClinicalTrials.gov directly typically spend 5 or more hours per week searching, reading, and filtering. TrialsAlert replaces that effort with a single 10-minute Friday briefing. If your time is worth more than EUR 11 per month, the math favors TrialsAlert.
Can I cancel anytime?
Yes. One click, no questions asked. Your subscription ends at the close of the current billing period with no cancellation fee.
The bottom line
ClinicalTrials.gov is indispensable and free. TrialsAlert is a monitoring and translation layer built specifically for patients and caregivers who do not have time to search a 400,000-trial database every week. If you want the authoritative registry, go to ClinicalTrials.gov. If you want the authoritative registry watched on your behalf and explained in plain English every Friday, TrialsAlert is the right ClinicalTrials.gov alternative for that job.